Arhaus Reports Second Quarter 2026 Financial Results

Arhaus reported Q2 2026 net revenue of $385M (+7.4% YoY) and adjusted EBITDA of $70M (+16.8% YoY), with results above the high end of guidance. Gross margin benefited from a $23.8M IEEPA tariff-recovery (including $15.5M tied to inventory sold prior to April 2026). Liquidity remained solid with $226M cash (no long-term debt), and the company maintained full-year net revenue/Comparable Delivered Sales guidance while updating net income and adjusted EBITDA to reflect tariff recovery benefits.

Analysis

This reads as a quality-of-earnings upgrade more than a clean fundamental inflection. The order trend implies revenue can stay ahead of consensus for the next 1-2 quarters, but the margin step-up is heavily padded by a tariff recovery that should not be annualized; once that rolls off, operating leverage depends on whether showroom productivity and custom mix keep improving.

The balance sheet is the real second-order positive: no debt, ample cash, and rising client deposits give management room to keep opening/refreshing locations without tapping credit, which lowers downside in a weaker consumer tape. That also makes ARHS a relative winner versus highly levered discretionary peers if rates stay restrictive, while premium mall owners and lifestyle-center landlords benefit from continued showroom expansion and relocation demand.

The contrarian risk is that the market may overread a one-time gross-margin tailwind as durable pricing power. SG&A grew faster than sales, so if written-to-delivered conversion cools or the consumer rolls over, earnings power can snap back quickly after the refund benefit is absorbed. Falsifiers: Q3 written sales dropping back below mid-single digits, delivered sales turning negative, or another quarter of SG&A outpacing revenue growth.

Key Decisions for Investors

• Buy ARHS on a pullback over the next 1-3 weeks rather than chasing the print; the stock has a credible 1-2 quarter catalyst path from order conversion, but size modestly because the margin beat is partly non-recurring.
• Use any post-earnings gap-up to sell short-dated upside via call spreads on ARHS; the risk/reward favors fading if the market starts capitalizing the tariff recovery as recurring EBITDA.
• If you want relative value, set up a long ARHS / short RH pair for 1-3 months only after confirming Q3 written-sales momentum; the thesis is cleaner balance-sheet optionality and less credit risk on ARHS.
• Watch for a deterioration in written sales or showroom traffic data; if delivered sales lag written sales for a second quarter in a row, reduce exposure because the operating leverage story is likely peaking.